Full sequencing analysis of estrogen receptor-alpha gene polymorphism and its association with breast cancer risk

Anticancer Res. 2003 Nov-Dec;23(6C):4703-7.

Abstract

Background: The estrogen receptor plays a critical role in breast cancer development and progression. So the genetic polymorphism of ER-alpha gene could affect cancer risk and phenotype.

Materials and methods: We fully sequenced the ER-alpha gene to investigate its single nucleotide polymorphisms (SNPs) in 100 breast cancer patients and 100 controls.

Results: Six novel polymorphism in the control and 11 in cancer patients were found. The G/G genotype at C975 G and A/A genotype at G1782 A had a protective effect against breast cancer when compared to other genotypes (OR = 0.3 and 0.3, respectively). 975G allele was associated inversely with the p53 expression and positively with the bcl-2 expression in cancer with borderline significance. Combining this result with our previous study, these associations became more significant (p = 0.005 and 0.019, respectively).

Conclusion: Polymorphisms in ER-alpha gene can affect the breast cancer susceptibility and may be related to other protein expression, such as p53 and bcl-2.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Amino Acid Substitution
  • Base Sequence
  • Breast Neoplasms / epidemiology*
  • Breast Neoplasms / genetics*
  • DNA Primers
  • Estrogen Receptor alpha
  • Female
  • Genetic Predisposition to Disease / genetics
  • Genotype
  • Humans
  • Polymorphism, Single Nucleotide*
  • Receptors, Estrogen / genetics*
  • Reference Values
  • Risk

Substances

  • DNA Primers
  • Estrogen Receptor alpha
  • Receptors, Estrogen